From June 8 to 12, 2026, the Asia-Pacific Regional Training Course in Nuclear Medicine, titled “Clinical Application of Therapeutic Radiotracers Labeled with Beta and Alpha Emitters”, was held in Xi’an. The course was jointly organized by the China Atomic Energy Authority (CAEA) and the International Atomic Energy Agency (IAEA) and ...
On June 10, the team led by Professor Yuan Zuyi from the First Affiliated Hospital (FAH) of Xi’an Jiaotong University (XJTU), in collaboration with Suzhou NGGT Biotechnology, announced a major clinical breakthrough in the world’s first gene therapy for homozygous familial hypercholesterolemia (HoFH). The findings were published in th...
Recently, the team led by Geng Zhimin from the Biliary Surgery Subspecialty of the Department of Hepatobiliary Surgery at the First Affiliated Hospital (FAH) of Xi’an Jiaotong University (XJTU) successfully performed laparoscopic radical resection of hilar cholangiocarcinoma on a 62-year-old Bangladeshi patient. The patient recovered,...
Recently, the 34th Annual Meeting of the International Society for Magnetic Resonance in Medicine (ISMRM) and the Annual Meeting of the International Society for MR Radiographers & Technologists (ISMRT) were held in Cape Town, South Africa. The meetings focused on cutting-edge technologies, innovative research, and clinical application...
Recently, the Department of Pediatrics at the Land Port Division of the First Affiliated Hospital (FAH) of Xi’an Jiaotong University (XJTU) successfully treated a critically ill 13-month-old child with Niemann-Pick disease type A, demonstrating the FAH’s outstanding capabilities in the diagnosis and treatment of rare pediatric diseas...
